Proof-of-principle: Oncogenic β-catenin is a valid molecular target for the development of pharmacological inhibitors

Molecular Cancer Therapeutics

Volumn 1, Issue 14, 2002, Pages 1355-1359

  Kim, Jung Sik ^a   Crooks, Heather ^a   Foxworth, Aaron ^a   Waldman, Todd ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CATNB PROTEIN, MOUSE; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; TRANSACTIVATOR PROTEIN;

ALLELE; ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL CULTURE; CELL DIVISION; CHEMISTRY; COLON TUMOR; DRUG SCREENING; GENETIC TRANSFECTION; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; NEOPLASM; TIME;

ALLELES; ANIMALS; BETA CATENIN; CELL DIVISION; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; DRUG EVALUATION, PRECLINICAL; HUMANS; MICE; MICE, KNOCKOUT; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASMS; TIME FACTORS; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037704269     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Polakis, P. Wnt signaling and cancer. Genes Dev., 14: 1837-1851, 2000. (Pubitemid 30639518)
2. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science (Wash. DC), 275: 1787-1790, 1997. (Pubitemid 27136715)
3. Miyoshi, Y., Iwao, K., Nagasawa, Y., Aihara, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T., and Nakamura, Y. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res., 58: 2524-2527, 1998. (Pubitemid 28275419)
4. Garcia-Rostan, G., Tallini, G., Herrero, A., D'Aquila, T. G., Carcangiu, M. L., and Rimm, D. L. Frequent mutation and nuclear localization of β-catenin in anaplastic thyroid carcinoma. Cancer Res., 59: 1811-1815, 1999. (Pubitemid 29186147)
5. Fukuchi, T., Sakamoto, M., Tsuda, H., Maruyama, K., Nozawa, S., and Hirohashi, S. β-catenin mutation in carcinoma of the uterine endometrium. Cancer Res., 58: 3526-3528, 1998. (Pubitemid 28376543)
6. Powell, S. M., Zilz, N., Beazer-Barclay, Y., Bryan, T. M., Hamilton, S. R., Thibodeau, S. N., Vogelstein, B., and Kinzler, K. W. APC mutations occur early during colorectal tumorigenesis. Nature (Lond.), 359: 235-237, 1992.
7. Furuuchi, K., Tada, M., Yamada, H., Kataoka, A., Furuuchi, N., Hamada, J., Takahashi, M., Todo, S., and Moriuchi, T. Somatic mutations of the APC gene in primary breast cancers. Am. J. Pathol., 156: 1997-2005, 2000. (Pubitemid 30641768)
8. Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T., Yamaoka, Y., and Nakamura, Y. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet., 24: 245-250, 2000. (Pubitemid 30132191)
9. Morin, P. J. β-catenin signaling and cancer. Bioessays, 21: 1021-1030, 1999.
10. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Identification of c-MYC as a target of the APC pathway. Science (Wash. DC), 281: 1509-1512, 1998. (Pubitemid 28425575)
11. Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D'Amico, M., Pestell, R., and Ben-Ze'ev, A. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA, 96: 5522-5527, 1999. (Pubitemid 29234650)
12. Tetsu, O., and McCormick, F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (Lond.), 398: 422-426, 1999. (Pubitemid 29180374)
13. Kim, J. S., Crooks, H., Dracheva, T., Nishanian, T. G., Singh, B., Jen, J., and Waldman, T. Oncogenic β-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. Cancer Res., 62: 2744-2748, 2002. (Pubitemid 34525754)
14. Roh, H., Green, D. W., Boswell, C. B., Pippin, J. A., and Drebin, J. A. Suppression of β-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells. Cancer Res., 61: 6563-6568, 2001. (Pubitemid 32783265)
15. Shih, I. M., Yu, J., He, T. C., Vogelstein, B., and Kinzler, K. W. The β-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. Cancer Res., 60: 1671-1676, 2000. (Pubitemid 30183440)
16. Naishiro, Y., Yamada, T., Takaoka, A. S., Hayashi, R., Hasegawa, F., Imai, K., and Hirohashi, S. Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of β-catenin/T-cell factor 4-mediated gene transactivation. Cancer Res., 61: 2751-2758, 2001. (Pubitemid 32685865)
17. van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A. P., Tjon-Pon-Fong, M., Moerer, P., van den Born, M., Soete, G., Pals, S., Eilers, M., Medema, R., and Clevers, H. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell, 111: 241-250, 2002. (Pubitemid 35292444)
18. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Wash. DC), 249: 912-915, 1990.
19. Brattain, M. G., Fine, W. D., Khaled, F. M., Thompson, J., and Brattain, D. E. Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res., 41: 1751-1756, 1981. (Pubitemid 11114567)
20. Chan, T. A., Wang, Z., Dang, L. H., Vogelstein, B., and Kinzler, K. W. Targeted inactivation of CTNNB1 reveals unexpected effects of β-catenin mutation. Proc. Natl. Acad. Sci. USA, 99: 8265-8270, 2002. (Pubitemid 34651041)
21. Sekine, S., Shibata, T., Sakamoto, M., and Hirohashi, S. Targeted disruption of the mutant β-catenin gene in colon cancer cell line HCT116: preservation of its malignant phenotype. Oncogene, 21: 5906-5911, 2002. (Pubitemid 35007241)
22. Dexter, D. L., Barbosa, J. A., and Calabresi, P. N. N-dimethylformamide- induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Res., 39: 1020-1025, 1979. (Pubitemid 9135128)
23. Sparks, A. B., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res., 58: 1130-1134, 1998. (Pubitemid 28183198)